Lilly Together™

3,0
25 ta sharh
1 ming+
Yuklanmalar
Yoshga oid cheklov
Hamma uchun
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot
Skrinshot

Bu ilova haqida

Lilly Together™ is designed to help you as a Taltz® (ixekizumab), Olumiant® (baricitinib), EBGLYSS® (lebrikizumab-lbkz), or Omvoh® (mirikizumab- mrkz) user to manage your condition.

Please see Indications and Safety Summary including WARNINGS for Olumiant® (baricitinib) at https://olumiant.lilly.com/?section=isi

The Lilly Together™ app is a resource to help you manage your treatment journey. Key Lilly Together features include:

· Plan Setup: Set up your dosing plan, schedule dosing reminders, and track when to take your medication.

· Treatment Map: View your treatment map for a summary of what to expect during your first 6 months of treatment, including treatment touchpoints, recommended dosing, and symptom tracking.

· Dose/Medication Tracking: Log your injections or infusions to view if you are staying on track and taking your medication as your Healthcare Provider prescribed.

· Symptom Tracking: Track and monitor your symptoms over time. You can take photos that will not appear in your camera roll to keep all your symptom information in one location.

· Progress: The app puts you in control of tracking your progress, which may help you to have better conversations with your Healthcare provider.

· Logbook Report: Download a logbook report for a 90-day view of your symptom and dosing trends. This may help you understand the progress you're making on treatment so you can share the information with your Healthcare Provider.

· Additional Features: The app also offers savings card enrollment, helpful resources, and one-click- away customer support

The app offers savings card enrollment, features to help you track dosing and treatment progress, helpful resources, and one-click-away support with your Companion in Care™ team* who can also answer any questions you might have about injection training and provide the ongoing support you may need.

Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Together™ is not intended to provide diagnostic and/or treatment decisions or replace the care and advice of a licensed Healthcare Provider. All medical analysis and treatment plans should be performed by a licensed Healthcare Provider.

Still have questions?
You can call for additional support at 1-844-486- 8546.

Lilly Together™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Omvoh® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

EBGLYSS® and its delivery device base registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Lilly Support Services™, and Companion in Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates

* Your Companion in Care provided is not a medical professional. Your doctor is your source for medical advice.

PP-LU-US-0732
Oxirgi yangilanish
9-apr, 2025

Maʼlumotlar xavfsizligi

Xavfsizlik — dastur ishlab chiquvchilar maʼlumotlaringizni qanday jamlashi va ulashishini tushunishdan boshlanadi. Maʼlumotlar maxfiyligi va xavfsizlik amaliyotlari ilovadan foydalanish, hudud va yoshga qarab farq qilishi mumkin. Bu axborot dastur ishlab chiquvchi tomonidan taqdim etilgan va keyinchalik yangilanishi mumkin.
Bu ilova tashqi hamkorlarga quyidagi turdagi maʼlumotlarini ulashishi mumkin
Men haqimda
Ushbu ilova quyidagi axborot turlarini toʻplashi mumkin
Men haqimda, Salomatlik va fitnes va yana 3 ta
Maʼlumotlar uzatish vaqtida shifrlanadi
Maʼlumotlarni oʻchirishni soʻrashingiz mumkin

Reytinglar va sharhlar

3,1
23 ta sharh

Nima yangiliklar

Medication and tracking support for adults with moderately to severely active Crohn’s disease and prescribed Omvoh® (mirikizumab-mrkz):
o Access information about your medication and possible savings
o Log your injections and view plan for upcoming doses
o Log and monitor your symptoms over time in the logbook
o Access a treatment map that allows you to see key steps in your treatment journey
o Create a logbook report that you can save and share outside of the app with your Healthcare Provider